Bill
LC 4317
LC 4317 broadly overhauls pharmacy laws, reshaping licensing, dispensing, controlled-substance rules, and patient protections for pharmacists, pharmacies, and patients.
Status and basic info
- Bill Number: LC 4317
- Title: Generally revise laws relating to pharmacies
- Status: Draft Ready for Delivery (LC)
- Introduced: January 16, 2025
- Classification: Bill
- Subject: Alcohol and Drugs
Overview and purpose
- The bill’s stated aim, based on the title, is to broadly revise the statutes governing pharmacies. The exact legislative text is not provided in the information available here, so the specific reforms are not yet enumerated.
- As a general pharmacy-law update, the bill could address topics such as licensing, practice standards, dispensing rules, controlled substances, patient protections, and related regulatory processes.
Key provisions (note: not yet available in the provided text)
- The actual provisions would be defined in the bill’s text. Typical areas a comprehensive pharmacy overhaul might cover include:
- Licensing, registration, and renewal requirements for pharmacists and pharmacies
- Scope of practice and professional standards for pharmacists
- Controlled substances, prescribing/dispensing rules, and prescription monitoring
- Pharmacy benefit management, pricing transparency, and patient protections
- Telepharmacy, remote dispensing, and technology-enabled services
- Recordkeeping, privacy, data sharing, and security of patient information
- Compounding, labeling, and safety/quality standards
- Inspections, enforcement, penalties, and licensure actions
- Transition provisions for existing licenses and regulatory compliance
- Specific provisions, thresholds, funding, and effective dates will be stated in the enacted text if the bill progresses.
Who would be affected
- Pharmacists and pharmacy personnel
- Retail and hospital pharmacies, compounding pharmacies, and mail-order providers
- Patients and consumers of prescription medications
- Prescribers and healthcare delivery systems
- Regulators and licensing boards overseeing pharmacy practice
- Pharmacy benefit managers and insurers
- Manufacturers and wholesalers involved in the distribution of medications
Procedural timeline and current status
- 2025-01-16: Drafter Assigned (initial drafting stage)
- 2025-01-16: Introduced
- 2025-01-19 to 2025-02-25: Series of drafting and review steps (Legal Review, Edit, Input/Proofing, Final Drafter Review, Assembly)
- 2025-02-24 to 2025-02-25: Drafts marked as Assembly, Input/Proofing, and Draft Ready for Delivery
- 2025-02-25: (LC) Draft Ready for Delivery
- Next steps: If advanced, the bill would move to committee hearings, potential amendments, and floor votes. The exact timeline depends on the legislative calendar and committee action.
Notes for readers
- The summary above reflects only the metadata and status information provided. The substantive provisions will determine the bill’s impact on practice, enforcement, and beneficiaries. Review the official bill text when available for detailed changes and effective dates.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
